Snail reproductive neuropeptide (APGWamide)
A tiny chemical messenger found in snail nervous systems that controls male reproductive organ growth; used only as a lab research tool.
A researcher, an agent, or an algorithm wrote down the sequence and picked a target to hit.
An AI model like OpenFold3 or AlphaFold built a 3D structure and scored how well it fits the binding site.
A second contributor repeated the computation on their own hardware and the scores matched.
A chemistry service or a researcher ordered the sequence, it was manufactured, and mass spectrometry confirmed the right molecule was produced.
A binding or activity measurement confirmed that it actually does what the computer predicted — or didn't.
What this is
APGWamide (Ala-Pro-Gly-Trp-NH₂) is a four-amino-acid neuropeptide found in the nervous systems of gastropod mollusks — snails, slugs, and their relatives. It acts as a chemical messenger controlling male reproductive behavior and the growth of male sex organs. The peptide is named for its amino-acid sequence and the C-terminal amide group that the raw four-letter sequence (APGW) does not display — the active molecule carries a –NH₂ cap at its C-terminus, which is essential for biological activity and stability. APGWamide has no known role in human or mammalian physiology; it is studied as a model neuropeptide in invertebrate biology and as a factor implicated in chemically induced reproductive disruption in marine snails.
History
APGWamide was first isolated in 1990 by Kuroki and colleagues from the neural ganglia of the marine snail Fusinus ferrugineus, where it was found to potentiate muscle contractions of the radula retractor muscle (Kuroki et al., Biochem Biophys Res Commun, 1990). The researchers noted that its sequence — H-Ala-Pro-Gly-Trp-NH₂ — was closely related to the C-terminal tetrapeptide of the crustacean red-pigment-concentrating hormone (RPCH), hinting at deep evolutionary conservation across invertebrate phyla.
Two years later, Smit and colleagues characterized a cDNA from Lymnaea stagnalis (the great pond snail) encoding a 219-amino-acid preprohormone that generates ten copies of the APGWamide precursor sequence per molecule (Smit et al., J Neurosci, 1992). This precursor architecture is similar to that of other invertebrate neuropeptide families. Expression was detected in neurons of the right anterior lobe of the cerebral ganglion in both adult and juvenile snails, consistent with a dedicated role in reproductive neurocircuitry. By 1998, de Lange and van Minnen had mapped APGWamide immunoreactivity across six gastropod species — including Lymnaea stagnalis, Aplysia californica, Bulinus truncatus, and Limax maximus — finding a conserved cluster of expressing neurons in the anteromedial cerebral ganglia in every species examined (de Lange & van Minnen, Gen Comp Endocrinol, 1998).
What it does
In gastropod mollusks, APGWamide coordinates male reproductive behavior from the central nervous system outward. Neurons producing the peptide innervate the muscles of male accessory sex organs, and injection of APGWamide into live animals triggers eversion of the preputium (the penial sheath), a step in the copulation sequence (Smit et al. 1992). Beyond this behavioral trigger, APGWamide modulates the contractile state of molluscan smooth muscle more broadly — it and structurally related peptides produce excitatory or inhibitory effects on different muscle preparations (Kuroki et al. 1990).
APGWamide also functions as a penis morphogenic factor (PMF): its endogenous concentration in gastropod tissue correlates with penis size, and males carry significantly higher levels than females under normal conditions (Oberdörster, Romano & McClellan-Green, Integr Comp Biol, 2005). When the marine pollutant tributyltin (TBT) causes female snails to grow male sex organs — a phenomenon called imposex — their APGWamide levels shift to match those of control males (Oberdörster, Romano & McClellan-Green 2005). This led Oberdörster and McClellan-Green (2000) to propose that TBT acts as a neurotoxin that abnormally releases APGWamide, driving imposex through the peptide's normal morphogenic signaling pathway (Oberdörster & McClellan-Green, Peptides, 2000). Three other neuropeptides tested in the same study — conopressin, LSSFVRIamide, and FMRFamide — did not induce imposex, indicating specificity. The threshold dose for APGWamide-induced imposex was near 10⁻¹⁶ moles in Ilyanassa obsoleta.
In the nudibranch Berghia stephanieae, the APGWamide gene is co-expressed with conopressin in a discrete trio of neurons located specifically in the right cerebral ganglion — the same side as the reproductive organs — and the conopressin receptor is prominently expressed in APGWamide-producing neurons, suggesting functional coordination between the two peptide systems in reproductive circuits (Tait et al., Peptides, 2024). However, bath application of APGWamide produced minimal behavioral changes in Berghia, pointing to context- or species-specific differences in how the peptide's signal is decoded (Tait et al. 2024).
Evidence
- Human: No human trials. APGWamide has no known role in human physiology and no registered clinical trials on ClinicalTrials.gov.
- Animal: Behavioral and morphological studies in gastropod species including Lymnaea stagnalis, Ilyanassa obsoleta, Aplysia californica, and Berghia stephanieae (Smit et al. 1992; Oberdörster & McClellan-Green 2000; Tait et al. 2024). Imposex-induction and penis-length correlation studies conducted in Ilyanassa obsoleta (Oberdörster et al. 2000, 2005).
- In vitro: Muscle contraction / relaxation assays across multiple molluscan preparations; antagonist structure–activity studies on crop and anterior byssus retractor muscle (ABRM) preparations (Ohtani, Minakata & Aimoto, Peptides, 2002).
Known effects
- Male copulation behavior (gastropods) — Preputium eversion and copulatory muscle coordination; Preclinical (mollusk models)
- Penial morphogenesis — Correlated with penis growth; acts as endogenous penis morphogenic factor (PMF) in multiple species; Preclinical
- Imposex induction — Threshold dose near 10⁻¹⁶ moles induces male organ development in female snails; implicated as the mediator of TBT-driven imposex; Preclinical
- Myogenic modulation — Excitatory or inhibitory effects on molluscan smooth muscle depending on preparation; Mechanistic only
- Antagonist-amenable target — Synthetic analogues of APGWGNamide developed as functional antagonists; improved variants show 50–100× greater potency in snail crop preparations; Mechanistic only
Safety signals
No safety data in humans or mammals. All published studies are in invertebrate models. The peptide's relevance to vertebrate toxicology is limited to its role as a proposed mediator of TBT-induced endocrine disruption in marine gastropods — a finding studied in environmental and ecotoxicological contexts rather than pharmaceutical ones.
Regulatory status
- US: Not an approved drug or regulated substance. No FDA designation.
- EU: No EMA designation.
- Research use: Commercially available as a synthetic research peptide. No clinical or veterinary approvals.
- WADA: Not listed.
Related peptides
APGWamide belongs to the wider AKH/RPCH superfamily of invertebrate neuropeptides — a group that includes insect adipokinetic hormones (AKH) and the crustacean red-pigment-concentrating hormone (RPCH), sharing the C-terminal Trp-amide motif and a common ancestral architecture. Within mollusks, it is functionally paired with conopressin (the mollusk oxytocin/vasopressin homolog) in reproductive neural circuits (Tait et al. 2024).
▸full evidence table2 metrics
| metric | value | tool |
|---|---|---|
| ipTM | 0.947134792804718 | boltz-2 |
| ranking score | 0.7699510455131531 | boltz-2 |
▸3-letter notation
▸recipeboltz-2 2.2.1
| parameter | value |
|---|---|
| model | boltz-2 2.2.1 |
| weights | — |
| hardware | vast_v100_32gb |
| mlx version | — |
| python | — |
| random seed | 1 |
| msa strategy | colabfold_local |
| runtime | — |
| predicted by | — |
| predicted at | 2026-05-22 |
▸citationbibtex
@peptide{pep10492,
sequence = {APGW},
target = {tacr1},
author = {peptidemodel},
year = {2026},
status = {synthesized}
}